Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Healthy: early-phase trial registry
225 of 1,096 indexed Healthy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2 of 28,707 conditions by registered trial count.
1,096 US clinical trials · 225 currently recruiting · #2 of 28,707 conditions by registered trial count
Healthy: 1,096 US clinical trials tracked, 225 recruiting.
Healthy is the subject of 1,096 registered US clinical trials on ClinicalTrials.gov, 225 of them currently open to new participants. 43 are in Phase 3-4 (later-stage) and 546 in Phase 1-2 (earlier-stage). The most active sponsor is Eli Lilly and Company, running 55 of these trials.
Enrollment posture brief
Registry condition healthy
OPEN 225 | RECR 21% | LATE 43 | EARLY 546 | RANK #2 | SPON 55
Volume-matched condition peers
Nearest open-share peer: Psoriasis (20% recruiting · 127 trials)
Healthy lists 225 open slots (21% of 1,096 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Healthy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Healthy is recruiting below its size-band peers.
225 of 1,096 indexed trials (20.5%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Healthy trials is spread across many organizations.
Eli Lilly and Company accounts for 55 of 1,096 trials (5%). 429 distinct sponsors appear on at least one study for this condition label.
-
Most Healthy trials plan to enrol fewer than 100 people.
Median target enrolment is 40 among the 1,091 trials that report a genuine target (sentinel values excluded). 851 of those (78%) plan for fewer than 100 participants.
-
Healthy research is mostly interventional.
905 interventional and 191 observational studies make up this index (82.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
1,096 total, page 11 of 22
A Phase I Study for Safety and Tolerability of AL002.
Alector
NCT03635047
Physiological Effects of Androstadienone Exposure
Rockefeller University
NCT00553384
A Study Comparing The Effects Of Epoetin Hospira Single-Dose Vial (SDV) And Multi-Dose Vial (MDV) When Administered Subcutaneously To Normal Healthy Subjects
Pfizer
NCT03398473
Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer
Duke University
NCT03719495
Clinical Performance of Masimo Rad-GT
Masimo Corporation
NCT05779397
PSG Validation Study of Zensorium Biosensing Wearable Device
University of California, San Diego
NCT04200495
Fasting Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg
Mylan Pharmaceuticals
NCT00649376
A Trial of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Healthy Subjects
Cyclerion Therapeutics
NCT02792998
Fed Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg
Mylan Pharmaceuticals
NCT00650494
A Study of Injections of LY3074828 in Healthy Participants
Eli Lilly and Company
NCT03886948
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-54767414 (Daratumumab) in Healthy Participants
Janssen Research & Development
NCT03320707
Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Healthy Han Chinese, Korean, Japanese, and Caucasian Participants and the Effects of Rifampin on the Pharmacokinetics of Intranasally Administered Esketamine
Janssen Research & Development
NCT02846519
Clarithromycin 500 mg Extended Release Tablets Under Fasting Conditions
Teva Pharmaceuticals U
NCT00840411
A Study of JNJ-70033093 (BMS-986177) in Healthy Adult Participants
Janssen Research & Development
NCT04223349
A Randomized, Double Blind Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy Subjects
Bristol-Myers Squibb
NCT02790125
Food Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg
Mylan Pharmaceuticals
NCT00650403
2-part Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of CC-220 & Effect of Food on CC-220 in Healthy Subjects
Celgene
NCT01733875
A Study to Evaluate Molnupiravir Tablet Formulation Compared to the Molnupiravir Capsule Formulation in Healthy Adult Participants (MK-4482-011)
Merck Sharp & Dohme
NCT06615869
A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Pioglitazone Hydrochloride When Given Together to Healthy Subjects
Astellas Pharma
NCT01088919
A First in Human Study in Healthy Volunteers and in Participants With Frontotemporal Dementia With Granulin (GRN) Mutation
Alector
NCT03636204
A Study to Evaluate the Effects of JNJ-54861911 on Electrocardiogram Intervals in Healthy Particiants
Janssen Research & Development
NCT02152332
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ACT-1004-1239 in Healthy Male Subjects
Idorsia Pharmaceuticals
NCT03869320
Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of TG-0054 With Single IV Doses Escalation in Healthy Volunteers
GPCR Therapeutics
NCT00822341
A Study to Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (50 mg/1,000 mg) With Respect to the Individual Components of Canagliflozin (1 x 100 mg) and Metformin IR Tablets (2 x 1,000 mg) in Healthy Volunteers
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
NCT01454622
The Effects of Continuous Administration of a Monophasic Oral Contraceptive on Bleeding Days and Endometrial and Ovarian Function
Milton S. Hershey Medical Center
NCT00128726
Amoxicillin Drug Interaction Study With MMX® Mesalazine/Mesalamine
Shire
NCT01442688
A Trial to Assess the Effects of Diets With and Without Inulin on Energy Expenditure in Adults.
Midwest Center for Metabolic and Cardiovascular Research
NCT06923332
Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly Participants
Takeda
NCT01456117
Drug-Drug Interaction (DDI) Study of ALXN2050 in Healthy Adult Participants
Alexion Pharmaceuticals
NCT05202145
Effects of Water-soluble Olive Extract Supplementation
University of Texas at Austin
NCT01113827
Citicoline Effects on Cortical Membrane Structure and Function
Kyowa Hakko Bio Co.
NCT02705066
Bioequivalence Study of Metformin HCl 750 mg XR Under Fasting Conditions
Ranbaxy Laboratories Limited
NCT00778791
A Study of LY2541546 in Healthy Postmenopausal Women
Eli Lilly and Company
NCT01742078
Valacyclovir 1000 mg Tablet Under Fasting Conditions
Teva Pharmaceuticals U
NCT01149499
A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD5847 After Multiple Doses Over 14 Days
AstraZeneca
NCT01116258
Mechanisms of Exercise-Induced Hypoalgesia
University of Central Florida
NCT06050889
A Study to Evaluate the Pharmacokinetics and the Effect on Cardiac Repolarization of Odalasvir Administered as a Single Dose Tablet Under Fed Conditions in Healthy Participants
Janssen Research & Development
NCT02889367
Surround Inhibition in Patients With Dystonia
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00029601
Metabolic Adaptations to Chronic and Acute Exercise in Overweight Adults (ATX-Study)
University of Michigan
NCT02701751
Fed Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg
Mylan Pharmaceuticals
NCT00649480
Fasting Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg
Mylan Pharmaceuticals
NCT00650481
Vibration Therapy Effects on Muscle Firing Patterns
Logan College of Chiropractic
NCT00510328
Dose Response of Intravenous Sincalide(CCK-8) for Gallbladder Emptying
Temple University
NCT00685477
Investigational Air-Activated Adhesive-Backed Heat Patch (3-Cell)
Chattem
NCT02241057
Effects of Ginseng and Ginkgo on Drug Disposition in Man
National Center for Complementary and Integrative Health (NCCIH)
NCT00029692
Audio-enhanced Analgesia in Healthy Subjects
Massachusetts General Hospital
NCT01835275
Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00001318
A Clinical Study of How Coffee and Tea Affect Enlicitide in Healthy Volunteers (MK-0616-040)
Merck Sharp & Dohme
NCT07044479
Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions
Teva Pharmaceuticals U
NCT00835276
Study of the Hypothalmic-Pituitary-Adrenal (HPA) Axis and Its Role in Major Depression
National Institute of Mental Health (NIMH)
NCT00001479
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 518 |
| Phase 2 | 28 |
| Phase 3 | 11 |
| Phase 4 | 32 |
Top Sponsors
Named interventions
Most-linked intervention names on Healthy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Healthy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Healthy page
1,096 registered trials, 225 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 225 Healthy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Eli Lilly and Company sponsors the most Healthy trials on record, review their full trial history before evaluating a specific study. See Eli Lilly and Company's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Healthy condition card totals 1,096 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.